Similarly, in cervical cancer, the overexpression of EZH2 promotes tumor progression by enhancing cell proliferation and tumor formation through activation of the Wnt/β-catenin pathway, achieved via epigenetic silencing of GSK-3β and TP53 [135]. The gene discussed is EZH2; the disease is neoplasm.